Cargando…

Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England

BACKGROUND: The COVID-19 pandemic has been highly disruptive for cancer care. Here, we examined the effect COVID-19 had on performance of the 62-day Cancer Waiting Time (CWT) target set by the National Health Service (NHS) in England. METHODS: Data were retrospectively obtained on COVID-19 hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Louis, Monroy-Iglesias, Maria J., Aggarwal, Ajay, Haire, Kate, Purushotham, Arnie, Spicer, James, Papa, Sophie, Rigg, Anne, Dolly, Saoirse, Sullivan, Richard, Van Hemelrijck, Mieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653402/ https://www.ncbi.nlm.nih.gov/pubmed/35559868 http://dx.doi.org/10.1016/j.jcpo.2021.100316

Ejemplares similares

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
por: Maringe, Camille, et al.
Publicado: (2020)

One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer
por: Moss, Charlotte, et al.
Publicado: (2020)

The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients
por: Purushotham, Arnie, et al.
Publicado: (2021)

Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK
por: Gheorghe, Adrian, et al.
Publicado: (2021)

Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic
por: Hadi, Hajer, et al.
Publicado: (2022)

The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer
por: Tremble, Kathryn, et al.
Publicado: (2022)

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
por: Russell, Beth, et al.
Publicado: (2020)

COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients
por: Russell, Beth, et al.
Publicado: (2021)

Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study
por: Aggarwal, Ajay, et al.
Publicado: (2017)

Report on the 1st Indian Cancer Congress 2013
por: Sullivan, Richard, et al.
Publicado: (2013)

“Something Good Has to Come Out of the Horror”: A Qualitative Examination of Cancer Survivors' Attitudes Towards Participation in Research During the First Year of the COVID-19 Pandemic
por: Fox, Louis, et al.
Publicado: (2021)

Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
por: Russell, Beth, et al.
Publicado: (2020)

Gender Differences in Concerns About Participating in Cancer Research During the COVID-19 Pandemic
por: Fox, Louis, et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
por: So, Alfred Chung Pui, et al.
Publicado: (2021)

CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer
por: Tsianakas, Vicki, et al.
Publicado: (2017)

Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London
por: Russell, Beth, et al.
Publicado: (2021)

Editorial: The effects of COVID-19 on cancer research methods & strategies
por: Fox, Louis, et al.
Publicado: (2022)

Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19
por: So, Alfred Chung Pui, et al.
Publicado: (2022)

CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer
por: Harris, Jenny, et al.
Publicado: (2015)

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020)

Family history of breast cancer and its association with disease severity and mortality
por: Melvin, Jennifer C., et al.
Publicado: (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre
por: Russell, Beth, et al.
Publicado: (2022)

Impact of the COVID‐19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan
por: Monroy‐Iglesias, Maria J., et al.
Publicado: (2022)

Monitoring access to nationally commissioned services in England
por: Coles, Suzanne, et al.
Publicado: (2012)

Guy’s cancer cohort – real world evidence for cancer pathways
por: Moss, C., et al.
Publicado: (2020)

Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?
por: George, Gincy, et al.
Publicado: (2023)

Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England
por: Møller, Henrik, et al.
Publicado: (2016)

Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
por: Russell, Beth, et al.
Publicado: (2022)

Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
por: Aggarwal, Ajay, et al.
Publicado: (2023)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England
por: Russell, Beth, et al.
Publicado: (2023)

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
por: Russell, Beth, et al.
Publicado: (2020)

Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022)

Brief behavioural intervention, delivered as standard care, to support physical activity engagement in men with prostate cancer: a pilot study protocol
por: Fox, Louis, et al.
Publicado: (2018)

An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
por: Moss, Miss Charlotte L., et al.
Publicado: (2021)

The influence of home care supply on delayed discharges from hospital in England
por: Allan, Stephen, et al.
Publicado: (2021)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ulnjjjvu537fsvs20nqgc7vmas